Inici › Colitis ulcerosa › Califòrnia › San Diego
Assaigs clínics de Colitis ulcerosa a San Diego, CA
15 estudis de Colitis ulcerosa busquen participants en centres de San Diego i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- Southern California Res. Ctr /ID# 280476, Coronado · a 2 mi
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
ReclutantFase 3
- Rady Children's Hospital /ID# 271873, San Diego
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Southern California GI and Liver Centers (SCLC), Coronado · a 2 mi
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ReclutantFase 2
- Site 023, La Jolla · a 11 mi
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Site US-018, San Diego
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
ReclutantFase 2
- Southern California Research Center ( Site 1044), Coronado · a 2 mi
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ReclutantFase 2
- Medical Associates Research Group, Inc., San Diego
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Medical Associates Research Group, Inc., San Diego
- Southern California Research Center, Coronado · a 2 mi
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado · a 2 mi
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Medical Associates Research Group, Inc., San Diego
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Clinical Applications Laboratories Inc - Site Number: 8400056, San Diego
- Medical Associates Research Group - Site Number: 8400063, San Diego
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado · a 2 mi
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Reclutant
- UC San Diego Health, La Jolla · a 11 mi
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ReclutantEstudi observacional
- Scripps Clinic Torrey Pines, La Jolla · a 11 mi
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ReclutantFase 3
- Rady Children's Hospital - San Diego - PIN, San Diego
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
ReclutantFase 2
- University of California San Diego, La Jolla · a 11 mi
Assaigs de Colitis ulcerosa en altres ciutats
- New York City, NY23 estudis
- Orlando, FL22 estudis
- Miami, FL21 estudis
- Houston, TX17 estudis
- San Antonio, TX16 estudis
- Tacoma, WA15 estudis
- Chicago, IL15 estudis
- Tyler, TX14 estudis
- Colorado Springs, CO14 estudis
- Los Angeles, CA13 estudis
- St. Louis, MO13 estudis
- Washington, DC12 estudis
Altres estudis a San Diego
- Càncer de pulmó de cèl·lules no petites48 estudis
- Càncer de mama41 estudis
- Càncer (tots els tipus)32 estudis
- Càncer de pròstata31 estudis
- Càncer metastàtic30 estudis
- Càncer colorrectal25 estudis
- Càncer de pàncrees24 estudis
- Càncer d'ovari24 estudis
- Càncer de pulmó23 estudis
- Insuficiència cardíaca23 estudis
- Obesitat23 estudis
- Depressió21 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.